Loading...
Uploaded by iambiotech on Feb 9, 2009
Dr. Ron Cohen, CEO and founder of Acorda Therapeutics, discusses his company's work on treatments for Multiple Sclerosis.
Science & Technology
Standard YouTube License
Load more suggestions
Link to this comment:
All Comments (0)